ICCM News and Press, IceCure Medical Ltd. From 11/03/23

IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire CAESAREA, Israel , Nov. 3, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), a developer of the ProSense® System, a minimally-invasive...

IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate Featured in a Presentation at BISICON 2023 in India PR Newswire ICE3 trial will be finalized in Q1 2024 IceCure's distributor in India , Novomed, exhibited ProSense® and received a ...

Independent Scientific Paper by Doctors Using IceCure's ProSense® Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients PR Newswire Paper cites IceCure's ICE3 interim clinical study resu...

2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...

2023-10-06 15:43:10 ET DENVER, Colo., Oct 6, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; IceCure Medical Ltd. (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), SeaStar Medical Holding (NASDAQ: ICU), Siyata Mobile (NASDAQ: SYTA), Vivos...

2023-10-05 12:21:19 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; IceCure Medical Ltd. (NASDAQ: ICCM), Grom Social Enterprises (NASDAQ: GROM), Euronav (NYSE: EURN), Maiso...

2023-10-05 10:10:30 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; IceCure Medical Ltd. (NASDAQ: ICCM), VS Media Holdings (NASDAQ: VSME), Vivos Therapeutics (NASDAQ: VVOS), Femas...

Women Deemed Inoperable for Breast Cancer Benefitted from IceCure Medical's ProSense as an Independent Study Performed in Italy Showed a Tumor Reduction Rate of 93.43% to 96.81% PR Newswire Disappearance of lesions and absence of residual malignant cells in Luminal-A ...

2023-10-02 12:50:19 ET DENVER, Colo., Oct 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Icecure Medical Ltd (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), AERWINS Technologies (NASDAQ: AWIN), Momentu...

2023-10-02 10:04:07 ET DENVER, Colo., Oct 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Icecure Medical Ltd (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), AERWINS Technologies (NASDAQ: AWIN), Invitae (NYSE:...